Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Morton

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Diabetes Research and Clinical Practice|January 12, 2023
Hospitalisation for mental health disorders in Australians with type 1 or type 2 diabetesDunya Tomic, Jedidiah I Morton, Agus Salim, et al.
Journal of General Internal Medicine|March 4, 2025
Current and Future Cost Burden of Myocardial Infarction in Australia: Dynamic Multistate Markov ModelTamrat Befekadu Abebe, Jenni Ilomaki, Adam Livori, et al.
Heart, Lung & Circulation|December 14, 2024
Reply to Letter to the Editor "Addressing Gaps in Post-MI Medication Use Study" regarding: "Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia"Adam C Livori, Zanfina Ademi, Jenni Ilomäki, et al.
Pharmacoeconomics|August 22, 2023
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness AnalysisJedidiah I Morton, Clara Marquina, Melanie Lloyd, et al.
Diabetes Care|May 24, 2021
Projecting the Incidence of Type 2 Diabetes-Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes TreatmentJedidiah I Morton, Stephen P McDonald, Agus Salim, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 31, 2022
Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetesOyunchimeg Buyadaa, Agus Salim, Jedidiah I Morton, et al.
Archives of Gerontology and Geriatrics|February 17, 2024
The impact of frailty on initiation, continuation and discontinuation of secondary prevention medications following myocardial infarctionHannah Doody, Justine Ayre, Adam Livori, et al.
International Journal of Medical Informatics|April 2, 2025
Identifying episodes of care in hospital admissions data for measures of disease burden: A tutorial and protocol for individual-level data analysisJedidiah I Morton, Adam Livori, Lee Nedkoff, et al.
Diabetes Research and Clinical Practice|November 28, 2022
Trends in diabetes-related foot disease hospitalizations and amputations in Australia, 2010 to 2019Matthew Quigley, Jedidiah I Morton, Peter A Lazzarini, et al.
Heart, Lung & Circulation|July 4, 2024
Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, AustraliaAdam C Livori, Zanfina Ademi, Jenni Ilomäki, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Diabetes Research and Clinical Practice|January 12, 2023
Hospitalisation for mental health disorders in Australians with type 1 or type 2 diabetesDunya Tomic, Jedidiah I Morton, Agus Salim, et al.
Journal of General Internal Medicine|March 4, 2025
Current and Future Cost Burden of Myocardial Infarction in Australia: Dynamic Multistate Markov ModelTamrat Befekadu Abebe, Jenni Ilomaki, Adam Livori, et al.
Heart, Lung & Circulation|December 14, 2024
Reply to Letter to the Editor "Addressing Gaps in Post-MI Medication Use Study" regarding: "Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia"Adam C Livori, Zanfina Ademi, Jenni Ilomäki, et al.
Pharmacoeconomics|August 22, 2023
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness AnalysisJedidiah I Morton, Clara Marquina, Melanie Lloyd, et al.
Diabetes Care|May 24, 2021
Projecting the Incidence of Type 2 Diabetes-Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes TreatmentJedidiah I Morton, Stephen P McDonald, Agus Salim, et al.
Therapeutic Advances in Endocrinology and Metabolism|March 31, 2022
Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetesOyunchimeg Buyadaa, Agus Salim, Jedidiah I Morton, et al.
Archives of Gerontology and Geriatrics|February 17, 2024
The impact of frailty on initiation, continuation and discontinuation of secondary prevention medications following myocardial infarctionHannah Doody, Justine Ayre, Adam Livori, et al.
International Journal of Medical Informatics|April 2, 2025
Identifying episodes of care in hospital admissions data for measures of disease burden: A tutorial and protocol for individual-level data analysisJedidiah I Morton, Adam Livori, Lee Nedkoff, et al.
Diabetes Research and Clinical Practice|November 28, 2022
Trends in diabetes-related foot disease hospitalizations and amputations in Australia, 2010 to 2019Matthew Quigley, Jedidiah I Morton, Peter A Lazzarini, et al.
Heart, Lung & Circulation|July 4, 2024
Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, AustraliaAdam C Livori, Zanfina Ademi, Jenni Ilomäki, et al.
Pageof 14